-+ 0.00%
-+ 0.00%
-+ 0.00%

Protagonist Therapeutics director William D. Waddill disposes of common shares worth $1.06 million

PUBT·06/25/2026 20:11:03
Listen to the news
Protagonist Therapeutics director William D. Waddill disposes of common shares worth $1.06 million
  • Protagonist Therapeutics director William D. Waddill sold 9,000 common shares on June 23, 2026 at USD 117.94.
  • He also exercised stock options for 9,000 shares at USD 16.54 in the same session.
  • Directly held common shares fell to 7,825 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-077761), on June 25, 2026, and is solely responsible for the information contained therein.